medmira 产品代理

HIV

REVEALCOVID-19™

Syphilis

Multiplex

Miriad

RVF Toolkit

H.Pylori

Our patented Rapid Vertical Flow Technology is the basis of MedMira’s robust product pipeline. It is a highly versatile product engine, enabling our team to quickly move new rapid testing applications through the discovery, design and development, and clinical phases to full commercialization. Our technology has been proven in highly complex regulatory markets around the world including the United States, Canada, Europe and China.

The technology facilitates the formation of highly specific antigen-antibody reactions allowing specific biomarkers in many sample types, including human whole blood, serum or plasma, to be captured and visualized on a unique membrane. The simple test procedure involves adding the specimen to the device and allowing it to flow through the membrane. If the specimen contains the target antibodies or antigens, they are captured on the test membrane and can be visually interpreted immediately after the addition of a detection reagent.

Our technology platform is unique in its ability to detect multiple biomarkers specific to several diseases using a single cartridge. Our Multiplo line of rapid tests for HIV, Hepatitis B and C, and syphilis uses the platform’s advanced capabilities to deliver up to four test results using one test cartridge and one drop of specimen.

Precision pipetting, sample manipulation, specialized equipment and training are not required to perform any of MedMira’s rapid tests, making it an invaluable diagnostic resource in a broad range of settings.